Colfax Corp. (CFX) Tops Q4 EPS by 5c, Revenues Beat; Offers FY20 EPS Mid-Point Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Colfax Reports Fourth Quarter 2019 Results
February 21, 2020 6:00 AM ESTÂ Â Â Â Reported $0.24 EPS from continuing operations and achieved $0.61 of adjusted EPS
       Delivered 7.5% year-on-year sales growth in Medical Technology segment including 7.8% organic improvement
       Improved Fabrication Technology operating income and adjusted EBITA margins by over 300 basis points
       Reaffirming 2020 adjusted EPS guidance of $2.10 to $2.20
ANNAPOLIS JUNCTION, MD, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the fourth quarter of 2019.
The Company reported net income from continuing operations of $33 million or $0.24 per share in the quarter, and $83 million of adjusted... More
